Reduced-cholesterol dairy product for use as a medicament
AssigneeCorman S.p.A.
InventorDaniel Dalemans
Life of this patent
Estimating the term…
Abstract
A ruminant reduced-cholesterol dairy product is used as a medicament.
Claims22
A cholesterol-reduced ruminant dairy product for use as a medicament, said dairy product comprising a cholesterol content between about 10 mg/100 g fat and about 150 mg/100 g fat.
A cholesterol-reduced ruminant dairy product supplemented with an ω3 fatty acid source selected from the group consisting of α-linolenic acid (ALA), Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA), wherein the dairy product comprises a cholesterol content is between 10 mg/100 g fat and 150 mg/100 g fat.
A method to increase the content in a mammal blood of long chain poly-unsaturated (ω3) fatty acid comprising administering to the mammal a ruminant dairy product for consumption by the mammal, wherein the ruminant dairy product comprises cholesterol content is between about 10 mg/100 g fat and about 150 mg/g fat.
A method to reduce triglyceride content in a mammal blood comprising administering to the mammal a ruminant dairy product for consumption by the mammal, wherein the ruminant dairy product comprises cholesterol content is between about 10 mg/100 g fat and about 150 mg/100 g fat.
A method for decreasing blood atherogenic ratio by at least about 10% in a mammal, comprising administering to the mammal a ruminant dairy product, for consumption by the mammal, wherein the ruminant dairy product comprises cholesterol content between about 10 mg/100 g fat and about 150 mg/100 g fat.
Dependencies are inferred from the claim text.